Women whose breast cancer spread to the lungs twice as likely to be smokers, says UC Davis study

June 10, 2001

(SACRAMENTO, Calif.) -- Here's one more reason for women to avoid smoking: breast cancer patients who smoke have a much higher risk of the disease spreading to their lungs than nonsmokers, says Susan Murin, an associate professor of medicine at the UC Davis School of Medicine and Medical Center. Her study and an editorial by two experts in the field appear in the June issue of the journal Chest.

Murin did a case control study of 87 UC Davis Cancer Center patients with invasive breast cancer that had spread to the lungs. She compared these women with 174 women with breast cancer that had not spread (metastasized). Each was matched by year of diagnosis, age at diagnosis, size of primary tumor and whether cancer was found in the lymph nodes.

Murin and John Inciardi, a UC Davis Medical Center statistician, found that women whose breast cancer had spread to the lungs were twice as likely to be smokers as women whose cancer had not metastasized. Breast cancer is the most common form of cancer in women, with more than 180,000 cases diagnosed annually. Caught early, five-year survival rates exceed 80 percent. But once it has spread to other parts of the body, it is much more difficult to treat.

Murin's study supports previous research linking smoking to a higher risk of lung metastasis among women with breast cancer and with studies showing that women who smoke are more likely to die of breast cancer than nonsmokers, even though smoking is not a risk factor for breast cancer.

It's an important distinction, said Murin, because while breast cancer is the most common cancer among women, lung cancer is the leading cause of cancer death among women.

"Women are in many ways more frightened of breast cancer than lung cancer, because it's so much more common. Everyone knows someone who has breast cancer," Murin said. "But women are more likely to survive breast cancer if they don't smoke. If we can let them know that, it might motivate some women to quit." The exact mechanism for spread is unclear, although Murin believes that cigarette smoke makes the lungs a more fertile environment for cancer.

"Smoking changes the immune function of the lungs and makes blood vessels more leaky," she said. "Once cancer cells escape the bloodstream, they are more likely to set up housekeeping in distant sites."

Still to be determined is whether other lifestyle factors might affect smoking, breast cancer and lung metastasis. "Smokers generally have less healthy diets and tend to exercise less than their nonsmoking counterparts," said Murin. "We need to further study this relationship."

Also in question is whether quitting smoking after breast cancer diagnosis limits this effect. Murin has received funding from the state Breast Cancer Research Program and the Tobacco-Related Diseases Program to examine the relationship of smoke exposure and lung metastasis in mice with breast tumors.

An accompanying editorial in Chest suggests that smokers who have been diagnosed with breast cancer should be offered support in quitting the habit.

Murin can be reached directly at 916-734-3564 or via e-mail at sxmurin@ucdavis.edu.
-end-
The American Cancer Society and the UC Davis Cancer Center funded this research.

University of California - Davis Health System

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.